Status:
COMPLETED
Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborating Sponsors:
Bayer
Conditions:
Trauma
Eligibility:
All Genders
19+ years
Brief Summary
Non-contrast MRI with T2 fat suppression has been a useful imaging modality in evaluation spinal trauma. However, the role of contrast enhancement has not investigated in patients with spinal trauma....
Eligibility Criteria
Inclusion
- Patients who provided the informed consent
- Patients with spinal trauma
- Patients with age of 19 years or more
Exclusion
- Relative contraindication of MR contrast
- previous history of any adverse event after injection of magnetic resonance contrast
- pregnant or breast-feeding state
- within 2 weeks after liver transplantation
- epileptic disorder
- Patients impossible with follow-up period of at least 2 months clinically
- Patients with severely impaired renal function of estimated glomerular filtration rate (GFR) \< 30 mL/min/1.73m2 and/or on dialysis
- patients with age less than 19 years
Key Trial Info
Start Date :
June 24 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 14 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01880944
Start Date
June 24 2013
End Date
February 14 2017
Last Update
October 5 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guen Young Lee
Seongnam-si, Gyenggi-do, South Korea, 463-707
2
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 763-707